Asaumi Makoto, Iijima Koichi, Sumioka Akio, Iijima-Ando Kanae, Kirino Yutaka, Nakaya Tadashi, Suzuki Toshiharu
Laboratory of Neurobiophysics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033.
J Biochem. 2005 Feb;137(2):147-55. doi: 10.1093/jb/mvi014.
The processing of beta-amyloid precursor protein (APP) generates the amyloid beta-protein (A beta) and contributes to the development of Alzheimer's disease (AD). Elucidating the regulation of APP processing will, therefore, contribute to the understanding of AD. Many APP-binding proteins, such as FE65, X11s, and JNK-interacting proteins (JIPs), bind the motif 681-GYENPTY-687 within the cytoplasmic domain of APP. Here we found that the human homologue of yeast amino-terminal acetyltransferase ARD1 (hARD1) interacts with a novel motif, 658-HGVVEVD-664, in the cytoplasmic domain of APP695. hARD1 expressed its acetyltransferase activity in association with a human subunit homologous to another yeast amino-acetyltransferase, hNAT1. Co-expression of hARD1 and hNAT1 in cells suppressed A beta40 secretion and the suppression correlated with their enzyme activity. These observations suggest that the association of APP with hARD1 and hNAT1 and/or their N-acetyltransferase activity contributes to the regulation of A beta generation.
β-淀粉样前体蛋白(APP)的加工会产生β-淀粉样蛋白(Aβ),并促使阿尔茨海默病(AD)的发展。因此,阐明APP加工过程的调控机制将有助于理解AD。许多与APP结合的蛋白,如FE65、X11s和JNK相互作用蛋白(JIPs),会与APP胞质结构域内的681-GYENPTY-687基序结合。我们在此发现,酵母氨基末端乙酰转移酶ARD1的人类同源物(hARD1)与APP695胞质结构域中的一个新基序658-HGVVEVD-664相互作用。hARD1与一个与另一种酵母氨基乙酰转移酶同源的人类亚基hNAT1共同表达其乙酰转移酶活性。hARD1和hNAT1在细胞中共表达可抑制Aβ40的分泌,且这种抑制作用与其酶活性相关。这些观察结果表明,APP与hARD1和hNAT1的结合及其N-乙酰转移酶活性有助于调控Aβ的生成。